TherapeuticsMD, Inc. Quarterly Interest Expense in USD from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
TherapeuticsMD, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q4 2023.
  • TherapeuticsMD, Inc. Interest Expense for the quarter ending December 31, 2023 was $185K.
  • TherapeuticsMD, Inc. Interest Expense for the twelve months ending December 31, 2023 was $300K, a 50% increase year-over-year.
  • TherapeuticsMD, Inc. annual Interest Expense for 2023 was $300K, a 50% increase from 2022.
  • TherapeuticsMD, Inc. annual Interest Expense for 2022 was $200K, a 99.4% decline from 2021.
  • TherapeuticsMD, Inc. annual Interest Expense for 2021 was $32.9M, a 15.2% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $300K $185K +$14.4M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$14.1M $20K +$20K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$14.1M $45K +$45K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$14.2M $50K -$14.4M -99.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $200K -$14.2M -$21.8M -288% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $22M $0 -$7.52M -100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $29.5M $0 -$7.6M -100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $37.1M $14.4M +$4.19M +40.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $32.9M $7.58M -$36K -0.47% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-07
Q3 2021 $33M $7.52M -$162K -2.11% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $33.1M $7.6M +$569K +8.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $32.5M $10.2M +$3.97M +63.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $28.6M $7.61M +$1.95M +34.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $26.6M $7.68M +$2.08M +37.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $24.6M $7.03M +$3M +74.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $21.6M $6.26M +$4.17M +200% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $17.4M $5.66M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-23
Q3 2019 $5.6M +$3.55M +173% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $4.03M +$3.5M +658% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $2.09M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q3 2018 $2.05M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $531K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q2 2013 $1.82M $150* -$1.15M Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $2.97M $1.17M +$1.06M +1043% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $1.91M $520K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-05
Q3 2012 $134K +$118K +715% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $1.15M +$1.15M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $102K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q3 2011 $16.5K -$39.1K -70.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $232* -$8.27K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q3 2010 $55.6K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $8.5K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.